Quince Therapeutics, Inc. - COM (QNCX)

Historical Portfolio Holders from Q2 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
7.24 M
Holdings value Q1 2024
$7.68 M
Value change Q1 2024
-$189 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
39
Number of buys Q1 2024
12
Number of sells Q1 2024
-15
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
22053A107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 7.24 M $7.68 M -$189 K $1.06 39
2023 Q4 7.42 M $7.79 M -$53.7 K $1.05 37
2023 Q3 7.48 M $8.38 M -$2.28 M $1.12 38
2023 Q2 8.95 M $13.5 M +$1.95 M $1.51 38
2023 Q1 7.62 M $11.9 M +$3.8 M $1.56 40
2022 Q4 5.35 M $3.41 M -$3.3 M $0.64 42
2022 Q3 8.87 M $11.8 M -$3.52 M $1.33 49
2022 Q2 10.7 M $23.8 M -$25.4 M $2.22 57
2022 Q1 11.1 M $68.8 M -$28 M $6.19 82
2021 Q4 16.4 M $207 M -$233 M $12.62 93
2021 Q3 19.2 M $1.76 B +$81.3 M $91.66 133
2021 Q2 18.5 M $982 M -$6.01 M $53.00 109
2021 Q1 18.7 M $673 M +$37.6 M $36.03 90
2020 Q4 17.6 M $490 M +$26.9 M $27.78 85
2020 Q3 16.5 M $826 M +$55.4 M $50.00 82
2020 Q2 15.4 M $715 M +$185 M $46.30 80
2020 Q1 11.4 M $523 M +$39.6 M $45.61 64
2019 Q4 10.6 M $594 M +$91.8 M $56.14 49
2019 Q3 5.84 M $145 M +$81.5 M $24.93 39
2019 Q2 2.42 M $103 M +$103 M $42.51 35